News

Study reveals new indicators for HER2+ breast cancer response to therapy
Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...
Breast cancer survivor organizing golf outing for those still battling
The "Fore The Fight: One Tough Titty Charity Golf Outing" is June 20 at Boulder Creek Golf Club. Foursomes can still sign up ...
Glasgow Times on MSN13h
Glasgow researchers get £400k funding to combat aggressive cancer
Researchers at the University of Glasgow have received £399,670 in funding from Breast Cancer Now and Secondary1st to develop ...
AI model achieves expert-level accuracy in non-invasive breast cancer diagnosis using MRI data
Researchers from the Hong Kong University of Science and Technology (HKUST) have developed Mixture of Modality Experts (MOME) ...
Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer
Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...
MPR17h
Sacituzumab Govitecan Meets Endpoint in First-Line mTNBC Trial
The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...